Jasper Therapeutics, Inc.JSPRNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Percentile
P0
Near historical low
vs 2Y Ago
-9.6x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2024-3.23-12705.3%
20230.03-92.4%
20220.34+262.3%
2021-0.21-
20200.00-
20190.00-